9 febrero 2015
Applying lessons learned from autism to brain cancer, researchers have discovered why elevated levels of the protein NHE9 add to the lethality of the most common and aggressive form of brain cancer, glioblastoma. Their discovery suggests that drugs designed to target NHE9 could help to successfully fight the deadly disease.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/FBPGnbrH4vI/150209095008.htm
